The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ1-42 fibrils in Alzheimer’s disease: insight from in-vitro and in-silico studies

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Biomolecular Structure and Dynamics

• Publication date

  2018-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/07391102.2017.1345326PMID 28633568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β42 monomer: insights from molecular dynamics simulations

  2018cited by this paper
• Nuclear Tau and Its Potential Role in Alzheimer’s Disease

  2016cited by this paper
• Distinct structural changes in wild-type and amyloidogenic chicken cystatin caused by disruption of C95–C115 disulfide bond

  2016cited by this paper
• Amyloid-β-Secondary Structure Distribution in Cerebrospinal Fluid and Blood Measured by an Immuno-Infrared-Sensor: A Biomarker Candidate for Alzheimer's Disease.

  2016cited by this paper
• Amyloid β-Protein Assembly and Alzheimer's Disease: Dodecamers of Aβ42, but Not of Aβ40, Seed Fibril Formation.

  2016cited by this paper
• Zinc-induced heterodimer formation between metal-binding domains of intact and naturally modified amyloid-beta species: implication to amyloid seeding in Alzheimer’s disease?

  2016cited by this paper
• Aβ(1–42) Fibril Structure Illuminates Self-recognition and Replication of Amyloid in Alzheimer’s

  2015cited by this paper
• Inhibition of amyloid-β plaque formation by α-synuclein

  2015cited by this paper
• Medicinal value of asiaticoside for Alzheimer’s disease as assessed using single-molecule-detection fluorescence correlation spectroscopy, laser-scanning microscopy, transmission electron microscopy, and in silico docking

  2015cited by this paper
• The dark sides of amyloid in Alzheimer's disease pathogenesis

  2014cited by this paper
• Chaperone‐like activity of β‐casein and its effect on residual in vitro activity of horseradish peroxidase

  2014cited by this paper
• Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.

  2014cited by this paper
• Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.

  2014cited by this paper
• The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

  2014cited by this paper
• The role of amyloid-beta in the regulation of memory.

  2014cited by this paper
• The γ-secretase complex: from structure to function

  2014cited by this paper
• The characteristics of heat-induced aggregates formed by mixtures of β-lactoglobulin and β-casein

  2014cited by this paper
• The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease.

  2013cited by this paper
• Molecular chaperone functions in protein folding and proteostasis.

  2013cited by this paper
• Structures of oligomers of a peptide from β-amyloid.

  2013cited by this paper
• Amyloid β-protein oligomers and Alzheimer’s disease

  2013cited by this paper
• The protective effect of crocin on the amyloid fibril formation of aβ42 peptide in vitro

  2013cited by this paper
• Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled β-casein micelles.

  2012cited by this paper
• Synaptotoxic Amyloid-β Oligomers: A Molecular Basis for the Cause, Diagnosis, and Treatment of Alzheimer's Disease?

  2012cited by this paper
• The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.

  2011cited by this paper
• Comparison of the Chaperoning Action of Glycerol and β-Casein on Aggregation of Proteins in the Presence of Crowding Agent

  2011cited by this paper
• Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease

  2011cited by this paper
• Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach.

  2011cited by this paper
• Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease

  2010cited by this paper
• Molecular mechanism of Thioflavin-T binding to amyloid fibrils.

  2010cited by this paper
• Self-assembly of bovine beta-casein below the isoelectric pH.

  2008cited by this paper
• Chaperone activities of bovine and camel beta-caseins: Importance of their surface hydrophobicity in protection against alcohol dehydrogenase aggregation.

  2008cited by this paper
• Preliminary studies to determine the chaperoning properties of bovine casein and crystallin proteins at reducing beef muscle protein aggregation during heating

  2008cited by this paper
• Amyloid-β Aggregation

  2007influential reference
• Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate.

  2007cited by this paper
• Amyloid-beta aggregation.

  2007cited by this paper
• Chaperone‐like activity and hydrophobicity of α‐crystallin

  2006cited by this paper
• Chaperone-like activity and hydrophobicity of alpha-crystallin.

  2006cited by this paper
• Effects of p-benzoquinone and melatonin on amyloid fibrillogenesis of hen egg-white lysozyme

  2006cited by this paper
• Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease

  2005cited by this paper
• Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.

  2005cited by this paper
• Casein proteins as molecular chaperones.

  2005cited by this paper
• Implication of C-Terminal Deletion on the Structure and Stability of Bovine β-casein

  2005cited by this paper
• Modulation of neurodegeneration by molecular chaperones

  2005cited by this paper
• Chaperone-like activity of beta-casein.

  2005cited by this paper
• Hsp20, a novel α‐crystallin, prevents Aβ fibril formation and toxicity

  2005cited by this paper
• Scalable molecular dynamics with NAMD

  2005influential reference
• Chaperone-like activity of β-casein

  2005influential reference
• Inhibition of amyloid fibrillogenesis and toxicity by a peptide chaperone

  2004cited by this paper
• Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain.

  2002influential reference
• De novo designed peptide-based amyloid fibrils

  2002cited by this paper
• Secondary structural studies of bovine caseins: temperature dependence of β-casein structure as analyzed by circular dichroism and FTIR spectroscopy and correlation with micellization

  2001cited by this paper
• Study of bovine β-casein at water/lipid interface by molecular modeling

  2001cited by this paper
• Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid.

  2000cited by this paper
• Alzheimer's amyloid fibrils: structure and assembly.

  2000influential reference
• Molecular Chaperone-like Properties of an Unfolded Protein, αs-Casein*

  1999cited by this paper
• From the globular to the fibrous state: protein structure and structural conversion in amyloid formation

  1998cited by this paper
• Temperature‐induced exposure of hydrophobic surfaces and its effect on the chaperone activity of α‐crystallin

  1995cited by this paper
• Review and update of casein chemistry.

  1993cited by this paper
• NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment.

  1992cited by this paper
• Proteins of Milk

  1988cited by this paper
• Mini Review Article

  year unknowncited by this paper

• Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics

  2023cites this paper
• Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's

  2022cites this paper
• Molecular modeling in drug discovery

  2022cites this paper
• Milk consumption and multiple health outcomes: umbrella review of systematic reviews and meta-analyses in humans

  2021cites this paper
• Functional and dysfunctional folding, association and aggregation of caseins.

  2019cites this paper
• Novel coumarin derivatives as potent acetylcholinesterase inhibitors: insight into efficacy, mode and site of inhibition

  2019cites this paper
• Proteostasis and the Regulation of Intra- and Extracellular Protein Aggregation by ATP-Independent Molecular Chaperones: Lens α-Crystallins and Milk Caseins.

  2018cites this paper
• The π–π stacking of tanshinone I and isotanshinone I with phenylalanine: The effects of isomerization, complexation and environment

  2017cites this paper